Headlands Technologies’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $394K | Buy |
+8,092
| New | +$394K | 0.05% | 357 |
|
|
2024
Q3 | – | Sell |
-3,440
| Closed | -$186K | – | 1248 |
|
|
2024
Q2 | $186K | Buy |
+3,440
| New | +$186K | 0.02% | 495 |
|
|
2023
Q4 | – | Sell |
-754
| Closed | -$34.2K | – | 1000 |
|
|
2023
Q3 | $34.2K | Buy |
+754
| New | +$34.2K | 0.02% | 505 |
|